DENTSPLY SIRONA (NASDAQ:XRAY) Releases Quarterly Earnings Results, Misses Estimates By $0.21 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.47 by ($0.21), Zacks reports. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA updated its FY 2025 guidance to 1.800-2.000 EPS.

DENTSPLY SIRONA Trading Down 8.8 %

XRAY traded down $1.66 on Thursday, reaching $17.15. 6,160,723 shares of the company traded hands, compared to its average volume of 2,461,708. DENTSPLY SIRONA has a one year low of $17.09 and a one year high of $34.91. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. The company has a market cap of $3.41 billion, a P/E ratio of -8.28, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The firm has a fifty day simple moving average of $18.90 and a two-hundred day simple moving average of $21.58.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.73%. DENTSPLY SIRONA’s dividend payout ratio is presently -30.92%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on the company. Barrington Research lowered their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating for the company in a research report on Friday, November 8th. Wells Fargo & Company assumed coverage on DENTSPLY SIRONA in a research report on Friday, February 14th. They issued an “equal weight” rating and a $20.00 target price for the company. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Tuesday, February 18th. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research note on Tuesday, December 3rd. Finally, Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price objective for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. Ten equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and a consensus target price of $24.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.